Insider Selling: Arteris, Inc. (NASDAQ:AIP) CEO Sells $601,329.96 in Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 58,212 shares of the company’s stock in a transaction on Monday, December 30th. The stock was sold at an average price of $10.33, for a total transaction of $601,329.96. Following the completion of the transaction, the chief executive officer now directly owns 10,020,588 shares of the company’s stock, valued at $103,512,674.04. This represents a 0.58 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link.

K Charles Janac also recently made the following trade(s):

• On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The shares were sold at an average price of $10.42, for a total value of $631,285.28.
• On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $141,941.80.
• On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total value of $180,702.72.
• On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total transaction of $10,656.36.

Arteris Stock Performance

NASDAQ AIP opened at $12.25 on Friday. The business has a 50 day simple moving average of $8.89 and a two-hundred day simple moving average of $8.05. Arteris, Inc. has a 1-year low of $4.83 and a 1-year high of $12.39. The stock has a market capitalization of $492.17 million, a PE ratio of -12.76 and a beta of 1.25. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16.

Analyst Ratings Changes

Separately, Rosenblatt Securities restated a “buy” rating and set a $15.00 target price on shares of Arteris in a research report on Wednesday, November 6th.

Hedge Funds Weigh In On Arteris

A number of institutional investors and hedge funds have recently made changes to their positions in the business. US Bancorp DE purchased a new position in shares of Arteris in the 3rd quarter worth approximately $34,000. The Manufacturers Life Insurance Company bought a new position in Arteris during the second quarter valued at $86,000. Algert Global LLC bought a new position in Arteris during the second quarter valued at $115,000. MetLife Investment Management LLC lifted its holdings in shares of Arteris by 129.1% in the 3rd quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after acquiring an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in shares of Arteris during the 3rd quarter worth about $226,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.